Clinical Scorecard: Outcomes of Robot-Assisted Laparoscopic Nephrectomy with Multimodal Analgesia and Intrathecal Morphine in Early Postoperative Care

At a Glance

Key Highlights

• Visceral pain predominates in the first 24 hours postoperatively and is challenging to manage with local anesthetics alone.
• Intrathecal morphine provides significant analgesia for approximately 24 hours at lower doses than systemic opioids but carries a risk of respiratory depression, especially with concurrent systemic opioids.
• Implementation of an APS-driven multimodal analgesia protocol including ITM was associated with decreased postoperative opioid use compared to surgeon-driven analgesia without ITM.

Guideline-Based Recommendations

Diagnosis

• Screen patients scheduled for RAPN and RARN for candidacy for intrathecal morphine considering contraindications such as anticoagulation, coagulopathy, morphine allergy, or patient refusal.

Management

• Administer preoperative ITM (200–300 mcg) based on age and renal function in the preoperative holding area.
• Use a perioperative multimodal analgesic regimen including scheduled acetaminophen and low-dose ketorolac postoperatively when renal function permits.
• Manage postoperative pain primarily by an acute pain service with scheduled non-opioid analgesics and as-needed intravenous opioids for breakthrough pain.
• Transition patients from intravenous to oral opioids on postoperative day 1, tailoring opioid type and dose based on individual opioid requirements, opioid naïve status, and age.
• Provide discharge opioid prescriptions based on inpatient opioid use rather than standard fixed prescriptions.

Monitoring & Follow-up

• Monitor for respiratory depression risks associated with ITM, especially when combined with systemic opioids.
• Assess pain control and opioid consumption during the first 72 hours postoperatively.
• Evaluate renal function to guide ketorolac use and analgesic dosing.

Risks

• Increased risk of respiratory depression with intrathecal morphine, particularly when combined with systemic opioids.
• Potential for inconsistent analgesic prescribing without acute pain service involvement.

Patient & Prescribing Data

Patients undergoing robot-assisted nephrectomy managed with or without acute pain service involvement

APS-driven multimodal analgesia including ITM reduced 24-hour postoperative opioid consumption compared to surgeon-driven protocols; tailored opioid prescribing based on inpatient use may optimize pain control and reduce opioid exposure.

Clinical Best Practices

• Incorporate acute pain service involvement for standardized multimodal analgesia protocols in robotic nephrectomy patients.
• Use preoperative intrathecal morphine judiciously after screening for contraindications to improve early postoperative analgesia.
• Employ scheduled non-opioid analgesics such as acetaminophen and ketorolac to reduce opioid requirements.
• Customize opioid prescribing postoperatively and at discharge based on individual patient opioid consumption and risk factors.
• Monitor patients closely for respiratory depression when neuraxial opioids are used alongside systemic opioids.

References

• Visceral pain predominance and local anesthetic limitations
• Intrathecal morphine analgesic efficacy and dosing
• Risks of respiratory depression with neuraxial opioids
• Use of ITM in laparoscopic urologic surgery
• ITM reduces opioid use in robot-assisted radical prostatectomy
• ITM benefits in laparoscopic bariatric surgery